🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
University of Galway to Lead New €64.5m Research Ireland Rinn Medical Devices Centre Chanelle Pharma Renews Historic Partnership with Galway Races Summer Festival 2026 The Distortion of Irish GDP: How 'Phantom Exports' Are Reshaping the Biopharma Landscape The Anatomy of a Biologics Warning Letter: Deconstructing Genzyme Waterford’s FDA Audit The Dublin-Backed Roll-Up Reshaping UK Pharma Packaging: Inside Woodberry's Double Acquisition The Pill That Promised a Revolution: Why Eli Lilly's Foundayo Is Launching Slower Than Wall Street Expected Speed Over Scrutiny? The High-Stakes Gamble Behind the NHS's New Fast-Track Drug Pilots A Global Milestone for Wellness: Chanelle McCoy Health Secures Historic Dual SFDA and European Novel Food Regulatory Approvals University of Galway to Lead New €64.5m Research Ireland Rinn Medical Devices Centre Chanelle Pharma Renews Historic Partnership with Galway Races Summer Festival 2026 The Distortion of Irish GDP: How 'Phantom Exports' Are Reshaping the Biopharma Landscape The Anatomy of a Biologics Warning Letter: Deconstructing Genzyme Waterford’s FDA Audit The Dublin-Backed Roll-Up Reshaping UK Pharma Packaging: Inside Woodberry's Double Acquisition The Pill That Promised a Revolution: Why Eli Lilly's Foundayo Is Launching Slower Than Wall Street Expected Speed Over Scrutiny? The High-Stakes Gamble Behind the NHS's New Fast-Track Drug Pilots A Global Milestone for Wellness: Chanelle McCoy Health Secures Historic Dual SFDA and European Novel Food Regulatory Approvals
Markets · 15 min delay
NBI4,187.6▲ +1.14%
PFE28.42▼ -0.38%
AZN74.18▲ +0.81%
NVO103.55▲ +2.07%
ROG261.40▼ -0.55%
ABBV174.92▲ +0.29%
EUR/USD1.0842▼ -0.12%
ISEQ9,241.3▲ +0.62%
NBI4,187.6▲ +1.14%
PFE28.42▼ -0.38%
AZN74.18▲ +0.81%
NVO103.55▲ +2.07%
ROG261.40▼ -0.55%
ABBV174.92▲ +0.29%
EUR/USD1.0842▼ -0.12%
Side-by-side · openFDA data

Compare Drugs

182 side-by-side comparisons of prescription medicines — what each one is, how it works, how it is taken, who makes it, when it was approved and whether it is in shortage. Grouped by drug class, plus the cross-class comparisons people ask about most.

3 comparisons
3 comparisons
3 comparisons
3 comparisons
10 comparisons
6 comparisons
3 comparisons
6 comparisons
1 comparison
10 comparisons
3 comparisons
1 comparison
6 comparisons
1 comparison
1 comparison
3 comparisons
6 comparisons
6 comparisons
3 comparisons
1 comparison
3 comparisons
1 comparison
Across drug classes
48 comparisons

Comparisons between drugs that work in different ways — usually the more interesting question, and the one people actually ask.

No comparisons match your search.

Comparisons combine editorial class summaries with live label, mechanism, route, manufacturer, approval and shortage data from the U.S. FDA via the openFDA API. For general information only — not medical advice, and not a recommendation of one drug over another. Two drugs in the same class are not automatically interchangeable. Related: Drug Directory · Drug Shortages Tracker · FDA Approvals